Repligen | RGEN - Cost Of Sales

Stock Price
142.18
Daily Change
2.52 1.80%
Monthly
-15.89%
Yearly
-8.89%
Q1 Forecast
144.77

Repligen reported $88.29M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Agilent USD 871M 28M Sep/2025
Align Technology USD 363.97M 7.48M Dec/2025
Bio Techne USD 104.6M 6.16M Dec/2025
BioMarin Pharmaceutical USD 144.93M 10M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Bruker USD 481.1M 41.6M Sep/2025
Charles River Laboratories USD 693.46M 20.52M Sep/2025
Danaher USD 2.87B 342M Dec/2025
Dentsply International USD 463M 17M Sep/2025
Exact Sciences USD 266.81M 18.18M Sep/2025
General Electric Aerospace USD 8.92B 654M Dec/2025
Henry Schein USD 2.38B 93M Sep/2025
Illumina USD 400M 49M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Myriad Genetics USD 61.9M 600K Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Repligen USD 88.29M 2.93M Sep/2025
Revvity USD 324.34M 3.38M Sep/2025
Standard Biotools USD 10.07M 1.06M Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Waters USD 327.81M 5.5M Sep/2025
West Pharmaceutical Services USD 510.3M 17.7M Sep/2025